AU3324700A - Imidazole compounds - Google Patents

Imidazole compounds

Info

Publication number
AU3324700A
AU3324700A AU33247/00A AU3324700A AU3324700A AU 3324700 A AU3324700 A AU 3324700A AU 33247/00 A AU33247/00 A AU 33247/00A AU 3324700 A AU3324700 A AU 3324700A AU 3324700 A AU3324700 A AU 3324700A
Authority
AU
Australia
Prior art keywords
imidazole compounds
imidazole
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33247/00A
Inventor
Hideyuki Aizawa
Jun-Ichi Endoh
Masataka Miura
Norio Ohno
Nobuyuki Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tokyo Pharmaceuticals Inc
Original Assignee
Mitsubishi Tokyo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tokyo Pharmaceuticals Inc filed Critical Mitsubishi Tokyo Pharmaceuticals Inc
Publication of AU3324700A publication Critical patent/AU3324700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33247/00A 1999-03-24 2000-03-22 Imidazole compounds Abandoned AU3324700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11/80349 1999-03-24
JP08034999A JP2003286266A (en) 1999-03-24 1999-03-24 Imidazole compound
PCT/JP2000/001738 WO2000056718A1 (en) 1999-03-24 2000-03-22 Imidazole compounds

Publications (1)

Publication Number Publication Date
AU3324700A true AU3324700A (en) 2000-10-09

Family

ID=13715794

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33247/00A Abandoned AU3324700A (en) 1999-03-24 2000-03-22 Imidazole compounds

Country Status (3)

Country Link
JP (1) JP2003286266A (en)
AU (1) AU3324700A (en)
WO (1) WO2000056718A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4629973B2 (en) * 2003-09-22 2011-02-09 第一三共株式会社 Optically active cyclopropylamine derivative and method for producing the same
EP1693364B1 (en) * 2003-12-12 2015-05-20 Daiichi Sankyo Company, Limited Intermediates for the production of optically active cyclopropylamine derivatives and process for the production of the intermediates
JP4503596B2 (en) * 2004-03-09 2010-07-14 独立行政法人科学技術振興機構 Method for producing cyclopentenenitrile derivative
EP1939183A4 (en) * 2005-07-25 2009-02-18 Mitsubishi Tanabe Pharma Corp Novel nitrogenated heterocyclic compound
EA200801591A1 (en) 2005-12-30 2008-12-30 Рэнбакси Лабораториз Лимитед MUSCARINE RECEPTOR ANTAGONISTS
US20090326004A1 (en) 2008-06-03 2009-12-31 Ranbaxy Laboratories Limited Muscarinic receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3294961B2 (en) * 1993-12-10 2002-06-24 杏林製薬株式会社 Novel imidazole derivative and method for producing the same
JPH07291936A (en) * 1994-03-01 1995-11-07 Kyorin Pharmaceut Co Ltd Novel imidazole derivative and its production
WO1999014200A1 (en) * 1997-09-18 1999-03-25 Mitsubishi-Tokyo Pharmaceuticals, Inc. Imidazoline compounds

Also Published As

Publication number Publication date
WO2000056718A1 (en) 2000-09-28
JP2003286266A (en) 2003-10-10

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1278701A (en) Novel compounds
AU2289700A (en) Triazole compounds with dopamine-d3-receptor affinity
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AU1746401A (en) Compounds
AU6032100A (en) New compounds
AUPQ441499A0 (en) Novel compound
AU3997700A (en) Anti-first-pass effect compounds
AU3324700A (en) Imidazole compounds
AU4132200A (en) Novel compounds
AU5887400A (en) Derivative compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AUPQ515700A0 (en) Imidazole compounds
AU6567400A (en) Substituted 2-imino-thiazolines
AU5251200A (en) Novel imidazole derivatives
AU5119400A (en) Compounds
AU2288900A (en) Novel compounds
AU6168900A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU7784700A (en) Novel compounds
AU4156800A (en) Novel compounds
AU1385701A (en) Novel compounds
AUPR636301A0 (en) Imidazole compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase